Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Published:2020-07 Issue:10246 Volume:396 Page:239-254
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mayer Kenneth H,Molina Jean-Michel,Thompson Melanie A,Anderson Peter L,Mounzer Karam C,De Wet Joss J,DeJesus Edwin,Jessen Heiko,Grant Robert M,Ruane Peter J,Wong Pamela,Ebrahimi Ramin,Zhong Lijie,Mathias Anita,Callebaut Christian,Collins Sean E,Das Moupali,McCallister Scott,Brainard Diana M,Brinson Cynthia,Clarke Amanda,Coll Pep,Post Frank A,Hare C Bradley

Publisher

Elsevier BV

Subject

General Medicine

Reference64 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

3. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

4. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

5. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation;Marcus;J Acquir Immune Defic Syndr,2016

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations Between PrEP Stigma, PrEP Confidence, and PrEP Adherence: Conditional Indirect Effects of Anticipated HIV Stigma;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Editorial: World AIDS Day 2022: putting ourselves to the test: achieving equity to end HIV;Frontiers in Public Health;2024-09-13

3. Development of a home-based pre-exposure prophylaxis care delivery system for long-acting injectable cabotegravir: a formative exploration of patient preferences;AIDS Care;2024-09-08

4. Integrated PrEP and STI Services for Transgender Women in Uganda: Qualitative Findings from a Randomized Trial;AIDS and Behavior;2024-09-02

5. Weight Gain and Antiretroviral Therapy;Infectious Disease Clinics of North America;2024-09